Related Experiment Video
Updated: Aug 4, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Dexmedetomidine Regulates Autophagy via the AMPK/mTOR Pathway to Improve SH-SY5Y-APP Cell Damage Induced by High
Pinzhong Chen1, Xiaohui Chen1, Honghong Zhang1
1Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134 Dong Street, Fuzhou, 350001, Fujian, People's Republic of China.
Abstract:
Neurodegenerative diseases and postoperative cognitive dysfunction involve the accumulation of β-amyloid peptide (Aβ). High glucose can inhibit autophagy, which facilitates intracellular Aβ clearance. The α2-adrenoreceptor agonist dexmedetomidine (DEX) can provide neuroprotection against several neurological diseases; however, the mechanism remains unclear. This study investigated whether DEX regulated autophagy via the AMPK/mTOR pathway to improve high glucose-induced neurotoxicity in SH-SY5Y/APP695 cells. SH-SY5Y/APP695 cells were cultured with high glucose with/without DEX. To examine the role of autophagy, the autophagy activator rapamycin (RAPA) and autophagy inhibitor 3-methyladenine (3-MA) were used. The selective AMPK inhibitor compound C was used to investigate the involvement of the AMPK pathway. Cell viability and apoptosis were examined by CCK-8 and annexin V-FITC/PI flow cytometric assays, respectively. Autophagy was analyzed by monodansylcadaverine staining of autophagic vacuoles. Autophagy- and apoptosis-related protein expression and the phosphorylation levels of AMPK/mTOR pathway molecules were quantified by western blotting. DEX pretreatment significantly suppressed high glucose-induced neurotoxicity in SH-SY5Y/APP695 cells, as evidenced by the enhanced viability, restoration of cellular morphology, and reduction in apoptotic cells. Furthermore, RAPA had a protective effect similar to that of DEX, but 3-MA eliminated the protective effect of DEX by promoting mTOR activation. Moreover, the AMPK/mTOR pathway was involved in DEX-mediated autophagy. Compound C significantly suppressed autophagy and reversed the protective effect of DEX against high glucose in SH-SY5Y/APP695 cells. Our findings demonstrated that DEX protected SH-SY5Y/APP695 cells against high glucose-induced neurotoxicity by upregulating autophagy through the AMPK/mTOR pathway, suggesting a role of DEX in treating POCD in diabetic patients.
Insights
Dexmedetomidine (DEX) protects against high glucose neurotoxicity by enhancing autophagy via the AMPK/mTOR pathway. This mechanism suggests DEX could treat postoperative cognitive dysfunction in diabetic patients.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Neurodegenerative diseases and postoperative cognitive dysfunction are linked to beta-amyloid peptide (Aβ) accumulation.
- High glucose levels can impair autophagy, a process crucial for clearing intracellular Aβ.
- Dexmedetomidine (DEX), an α2-adrenoreceptor agonist, shows neuroprotective potential, but its mechanism is unclear.
Purpose of the Study:
- To investigate if DEX upregulates autophagy through the AMPK/mTOR pathway.
- To determine if DEX mitigates high glucose-induced neurotoxicity in SH-SY5Y/APP695 cells.
Main Methods:
- SH-SY5Y/APP695 cells were exposed to high glucose with or without DEX, rapamycin (RAPA), 3-methyladenine (3-MA), or compound C.
- Cell viability, apoptosis, and autophagy were assessed using CCK-8, flow cytometry, and monodansylcadaverine staining.
- Protein expression and phosphorylation of AMPK/mTOR pathway components were analyzed via western blotting.
Main Results:
- DEX significantly reduced high glucose-induced neurotoxicity, improving cell viability and reducing apoptosis.
- Autophagy modulation (RAPA, 3-MA) affected DEX's protective effects, indicating its involvement.
- DEX-induced autophagy was mediated by the AMPK/mTOR pathway, as confirmed by compound C inhibition.
Conclusions:
- DEX protects against high glucose neurotoxicity by enhancing autophagy via the AMPK/mTOR pathway in neuronal cells.
- This study elucidates a novel mechanism for DEX's neuroprotection.
- DEX may be a potential therapeutic agent for postoperative cognitive dysfunction in diabetic patients.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway